Press Room

JDRF Partners with InnoCentive to Launch a Challenge for the Treatment of Diabetes

Waltham, Mass.—September 8, 2011—The Juvenile Diabetes Research Foundation (JDRF), the worldwide leader for research to cure, treat, and prevent type 1 diabetes, and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, today announced a $100,000 Challenge calling for innovative ...


JDRF applauds the Saskatchewan Party for Its Commitment to People with Diabetes

TORONTO, October 25, 2011 – The Juvenile Diabetes Research Foundation (JDRF) applauds the Saskatchewan party for its commitment to diabetes.


JDRF applauds the Government of Canada for its commitment to Canadians living with diabetes

TORONTO (November 1, 2011) – As a member of the Diabetes Partnership developed as a result of the Canadian Diabetes Strategy (CDS),  JDRF applauds the Government of Canada’s announcement of funding for 37 new community-based projects to support Canadians who live with diabetes and its ...


New Study Aims to Increase Adoption of Advanced Diabetes Technology in Young People with T1D

Ottawa, ON (November 3, 2011) – JDRF Canadian Clinical Trial Network (JDRF CCTN) is pleased to announce the launch of the first multi-centre pediatric study in Canada using insulin pump therapy and continuous glucose monitoring (CGM). Based at the Children’s Hospital of Eastern Ontario (CHEO) ...


JDRF Applauds the Government of Canada’s CANRISK Questionnaire

TORONTO (November 14, 2011) – As a member of the Diabetes Partnership developed as a result of the Canadian Diabetes Strategy (CDS), JDRF applauds the Government of Canada’s announcement on the release of the Canadian Diabetes Risk Questionnaire (CANRISK). CANRISK will expand the reach of ...


JDRF Open Letter

National Philanthropy Day is celebrated in hundreds of communities throughout North America by numerous fundraisers, government leaders, businesses and individuals who wish to honour all the contributions philanthropy has made.


JDRF-Funded Study Seeks to Reduce Cardiovascular Risk in Adults with Type 1 Diabetes

New York, NY, December  13, 2011-JDRF-funded researchers have begun enrolling adult patients with type 1 diabetes (T1D) in the REMOVAL study, to test whether metformin-a drug commonly used to treat type 2 diabetes-could help prevent or reduce the risk of cardiovascular complications in people with ...


JDRF Applauds the Government of Saskatchewan for Enhancing Support for Individuals Living with Diabetes

TORONTO (December 14, 2011) – JDRF applauds the Government of Saskatchewan for following through on its commitment to provide additional support for individuals living with diabetes.


JDRF Applauds the Government of Canada’s Report

TORONTO (December 15, 2011) – JDRF applauds The Government of Canada’s leadership in releasing the report “Diabetes in Canada: Facts and Figures from a Public Health Perspective.” This comprehensive report will help support the development of health policies and programs aimed ...


Response to Government of Nova Scotia’s Decision to Not Cover Insulin Pumps

December 15, 2011 – It is unfortunate for the thousands of people with diabetes in the province who require insulin pumps and their families that the government has decided not to extend public funding for an insulin pump program. Studies have shown that people living with type 1 diabetes that ...


Lets turn type one into type none